『ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research』のカバーアート

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

著者： American College of Cardiology
無料で聴く

概要

 The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.American College of Cardiology Foundation. All rights reserved. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Cardiovascular-Kidney Therapies in CKD

    Cardiovascular-Kidney Therapies in CKD
    2026/03/17

    Heart and kidney disease are closely linked, as individuals with chronic kidney disease (CKD) face a significantly higher risk of cardiovascular events and heart failure. Because this cardiometabolic connection is so strong, identifying high‑risk individuals early is essential to preventing progression of both conditions. A holistic approach—including guideline‑directed therapies that target blood pressure, glucose, and inflammation—can simultaneously lower the risk of heart disease and slow kidney decline. Newer treatments now allow clinicians to address both organs together, improving long‑term health outcomes.

    In this interview, Allen J. Taylor, MD, FACC and Janani Rangaswami, MD examine "Cardiovascular-Kidney Therapies in CKD". 

    続きを読む 一部表示
    13 分
  • Prasugrel Benefits Patients With Diabetes and Multivessel Disease Post-PCI: TUXEDO-2 Trial

    Prasugrel Benefits Patients With Diabetes and Multivessel Disease Post-PCI: TUXEDO-2 Trial
    2026/03/10

    The findings from the TUXEDO‑2 trial provide important clinical insights for managing high‑risk patients with diabetes and multivessel coronary disease undergoing stenting. By directly comparing ticagrelor and prasugrel within a dual antiplatelet therapy regimen, the trial helps clarify whether one agent offers superior protection in this complex population. These results may influence clinical decision‑making, particularly if meaningful differences in outcomes are demonstrated.

    In this interview, Sidney C. Smith Jr., MD, MACC and Sripal Bangalore, MD, MHA discuss the TUXEDO-2 Trial.

     

    続きを読む 一部表示
    12 分
  • The Power of Nutrition: GOFRESH Trial

    The Power of Nutrition: GOFRESH Trial
    2026/03/03
    The GOFRESH trial showed that providing DASH‑patterned groceries through a structured grocery‑ordering strategy meaningfully lowered systolic blood pressure and LDL cholesterol among Black families living in a Boston‑area food desert. These results highlight the powerful role of nutrition by showing that accessible, culturally relevant food‑as‑medicine strategies can deliver measurable cardiovascular benefits while helping reduce disparities and equipping patients with practical tools for healthier living. In this interview, Cindy L. Grines MD, FACC and Stephen Juraschek, MD, PhD discuss how findings from the GOFRESH trial may be used to improve hypertension management and overall patient care.  Turkson-Ocran RN, Cluett JL, Fitzpatrick SL, et al. Rationale and Design of the Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension (GoFresh) Trial. Am J Hypertens. 2023;36(5):256-263. doi:10.1093/ajh/hpad008 Ferro KM, Seager R, McManus K, et al. Nutrition Intervention of Groceries for Black Residents of Boston to Stop Hypertension (GoFresh) Among Adults With or Without Treated Hypertension Trial: Rationale, Design, and Evidence to Promote Implementation. Preprint. Res Sq. 2025;rs.3.rs-6222158. Published 2025 Jul 7. doi:10.21203/rs.3.rs-6222158/v1
    続きを読む 一部表示
    13 分
まだレビューはありません